Research ArticleDosimetry
Dosimetry and Risk Estimates of Radioiodine Therapy for Large, Multinodular Goiters
Dyde A.K.C. Huysmans, Wilhelmina C.A.M. Buijs, Marjo T.P. van de Ven, Wim J.M. van den Broek, Peter W.C. Kloppenborg, Ad R.M.M. Hermus and Frans H.M. Corstens
Journal of Nuclear Medicine December 1996, 37 (12) 2072-2079;
Dyde A.K.C. Huysmans
Wilhelmina C.A.M. Buijs
Marjo T.P. van de Ven
Wim J.M. van den Broek
Peter W.C. Kloppenborg
Ad R.M.M. Hermus
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Dosimetry and Risk Estimates of Radioiodine Therapy for Large, Multinodular Goiters
Dyde A.K.C. Huysmans, Wilhelmina C.A.M. Buijs, Marjo T.P. van de Ven, Wim J.M. van den Broek, Peter W.C. Kloppenborg, Ad R.M.M. Hermus, Frans H.M. Corstens
Journal of Nuclear Medicine Dec 1996, 37 (12) 2072-2079;
Jump to section
Related Articles
- No related articles found.
Cited By...
- THERAPY OF ENDOCRINE DISEASE: Recombinant human TSH and radioactive iodine therapy in the management of benign multinodular goiter
- Cancer risk after medical exposure to radioactive iodine in benign thyroid diseases: a meta-analysis
- Dosimetry of Radioiodine Therapy in Patients with Nodular Goiter After Pretreatment with a Single, Low Dose of Recombinant Human Thyroid-Stimulating Hormone